UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor

Journal of medicinal chemistry, 2014-03, Vol.57 (5), p.1673-1693

2014

Volltextzugriff (PDF)

Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (46), p.20057-20062

2010

Volltextzugriff (PDF)

Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands

Journal of medicinal chemistry, 2019-08, Vol.62 (15), p.6843-6853

2019

Volltextzugriff (PDF)

In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.1878-1887

2010

Volltextzugriff (PDF)

Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?

ACS omega, 2018-09, Vol.3 (9), p.11742-11757

2018

Volltextzugriff (PDF)

Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target

Angewandte Chemie (International ed.), 2010-02, Vol.49 (9), p.1652-1655

2010

Volltextzugriff (PDF)

Structure-Based Site of Metabolism Prediction for Cytochrome P450 2D6

Journal of medicinal chemistry, 2011-09, Vol.54 (17), p.6098-6105

2011

Volltextzugriff (PDF)

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (1), p.308-313

2010

Volltextzugriff (PDF)

TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4676-4684

2012

Volltextzugriff (PDF)

Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase

Journal of medicinal chemistry, 2009-07, Vol.52 (14), p.4099-4102

2009

Volltextzugriff (PDF)

Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits

The Journal of pharmacology and experimental therapeutics, 2020-12, Vol.375 (3), p.510-521

2020

Volltextzugriff (PDF)

1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors

Antimicrobial Agents and Chemotherapy, 2008-12, Vol.52 (12), p.4420-4431

2008

Volltextzugriff (PDF)

1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C Virus

Journal of Virology, 2010-03, Vol.84 (6), p.2923-2934

2010

Volltextzugriff (PDF)

Virologic response and characterisation of HCV genotype 2–6 in patients receiving TMC435 monotherapy (study TMC435-C202)

Journal of hepatology, 2013-03, Vol.58 (3), p.445-451

2013

Volltextzugriff (PDF)

Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation

Proceedings of the National Academy of Sciences - PNAS, 2014-08, Vol.111 (33), p.12163-12168

2014

Volltextzugriff (PDF)

Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase

Acta crystallographica. Section D, Biological crystallography., 2002-07, Vol.58 (7), p.1182-1192

2002

Volltextzugriff (PDF)

Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease

Bioorganic & medicinal chemistry letters, 2019-12, Vol.29 (23), p.126743-126743, Article 126743

2019

Volltextzugriff (PDF)

Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy

Bioorganic & medicinal chemistry letters, 2018-07, Vol.28 (12), p.2159-2164

2018

Volltextzugriff (PDF)

Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt

Bioorganic & medicinal chemistry letters, 2020-06, Vol.30 (12), p.127205-127205, Article 127205

2020

Volltextzugriff (PDF)

Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach

Bioorganic & medicinal chemistry letters, 2020-06, Vol.30 (12), p.127174-127174, Article 127174

2020

Volltextzugriff (PDF)

Identification and biological evaluation of thiazole-based inverse agonists of RORγt

Bioorganic & medicinal chemistry letters, 2018-05, Vol.28 (9), p.1446-1455

2018

Volltextzugriff (PDF)

Comparison of Automated Docking Programs as Virtual Screening Tools

Journal of medicinal chemistry, 2005-02, Vol.48 (4), p.962-976

2005

Volltextzugriff (PDF)

Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt

Bioorganic & medicinal chemistry letters, 2017-05, Vol.27 (9), p.2047-2057

2017

Volltextzugriff (PDF)

6-Substituted quinolines as RORγt inverse agonists

Bioorganic & medicinal chemistry letters, 2017-12, Vol.27 (23), p.5277-5283

2017

Volltextzugriff (PDF)

Universal screening methods and applications of ThermoFluor

Journal of biomolecular screening, 2006-10, Vol.11 (7), p.854-863

2006

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(83)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(56)
Pharmacology & Pharmacy
(40)
Humans
(37)
Chemistry, Medicinal
(34)
Chemistry
(27)
Structure-Activity Relationship
(27)
Models, Molecular
(24)
Physical Sciences
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Pharmacology. Drug Treatments
(20)
Chemistry, Organic
(19)
Crystallography, X-Ray
(19)
Molecular Structure
(19)
Animals
(18)
Binding Sites
(16)
Viral Nonstructural Proteins - Antagonists & Inhibitors
(14)
Drug Design
(12)
Protein Binding
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor

Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance

Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands

In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?

Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target

Structure-Based Site of Metabolism Prediction for Cytochrome P450 2D6

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein

TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage

Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase

Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits

1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors

1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C Virus

Virologic response and characterisation of HCV genotype 2–6 in patients receiving TMC435 monotherapy (study TMC435-C202)

Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation

Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase

Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease

Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy

Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt

Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach

Identification and biological evaluation of thiazole-based inverse agonists of RORγt

Comparison of Automated Docking Programs as Virtual Screening Tools

Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt

6-Substituted quinolines as RORγt inverse agonists

Universal screening methods and applications of ThermoFluor

Suchergebnisse filtern